Genetic Engineering & Biotechnology News

DEC 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: https://gen.epubxp.com/i/1052771

Contents of this Issue

Navigation

Page 28 of 57

Intensify and Evolve. Together. Explore The BioContinuum ™ Platform The BioContinuum ™ Platform is the next evolution in bioprocessing, empowering biomanufacturers to confidently enter the era of next generation processing and make the factory of the future a reality. With proven and novel technologies, connected software, applications and expert support, our platform enables you to increase speed, flexibility and reliability through intensified, connected or continuous manufacturing. In collaboration with you, the BioContinuum ™ Platform is ready to accelerate access to biopharmaceuticals for patients worldwide. Let's Explore What's Next at EMDMillipore.com/BioContinuum MS_AD2734EN Ver. 1.0 The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada. © 2018 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. MilliporeSigma, the vibrant M, and BioContinuum are trademarks of Merck KGaA, Darmstadt, Germany and/or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources.

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - DEC 2018